Barclays’s Tango Therapeutics TNGX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $710K | Buy |
138,650
+75,618
| +120% | +$387K | ﹤0.01% | 2849 |
|
|
2025
Q1 | $86K | Sell |
63,032
-36,742
| -37% | -$50.1K | ﹤0.01% | 3742 |
|
|
2024
Q4 | $307K | Sell |
99,774
-26,507
| -21% | -$81.6K | ﹤0.01% | 3319 |
|
|
2024
Q3 | $972K | Buy |
126,281
+55,470
| +78% | +$427K | ﹤0.01% | 2639 |
|
|
2024
Q2 | $608K | Sell |
70,811
-112,675
| -61% | -$967K | ﹤0.01% | 2418 |
|
|
2024
Q1 | $1.46M | Sell |
183,486
-18,413
| -9% | -$146K | ﹤0.01% | 2149 |
|
|
2023
Q4 | $2M | Buy |
201,899
+114,017
| +130% | +$1.13M | ﹤0.01% | 2160 |
|
|
2023
Q3 | $990K | Buy |
87,882
+31,618
| +56% | +$356K | ﹤0.01% | 2103 |
|
|
2023
Q2 | $187K | Sell |
56,264
-3,265
| -5% | -$10.9K | ﹤0.01% | 3119 |
|
|
2023
Q1 | $235K | Sell |
59,529
-22,993
| -28% | -$90.8K | ﹤0.01% | 3056 |
|
|
2022
Q4 | $599K | Sell |
82,522
-37,193
| -31% | -$270K | ﹤0.01% | 2484 |
|
|
2022
Q3 | $433K | Sell |
119,715
-19,121
| -14% | -$69.2K | ﹤0.01% | 2676 |
|
|
2022
Q2 | $629K | Buy |
138,836
+15,927
| +13% | +$72.2K | ﹤0.01% | 2404 |
|
|
2022
Q1 | $932K | Buy |
+122,909
| New | +$932K | ﹤0.01% | 2375 |
|